Clinical Trial Update: Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 pragmatic trial evaluating sentinel lymph node biopsy in high-risk clinically node-negative cutaneous squamous cell carcinoma of the head and neck; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma of the Head and Neck

Snippet

Sponsor: University of California, Davis | Conditions: Cutaneous Squamous Cell Carcinoma of the Head and Neck, Clinically Node-Negative (cN0) | Phase 2 | Status: RECRUITING